

<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="https://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Avicenna J Med Biotech</journal-id>
      <journal-id journal-id-type="publisher-id">arij002</journal-id>
      <journal-title-group>
        <journal-title>Avicenna Journal of Medical Biotechnology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2008-2835</issn>
      <issn pub-type="epub">2008-4625</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>

    <article-meta>
      <article-id pub-id-type="publisher-id">ajmb60565</article-id>
      <article-id pub-id-type="doi"></article-id>
      <article-id pub-id-type="pmid"></article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
             <subject></subject> 
        </subj-group>
        <subj-group>
            <subject></subject>
        </subj-group> 
      </article-categories>
      <title-group>
        <article-title>Extracellular L-Asparaginase Synthesis Bacillus niacin Isolation, Optimization, and Characterization from Marine Saltern Sediment Sources</article-title>
      </title-group>
        <contrib-group><contrib contrib-type="author"><name><surname>Abdul Wahab </surname><given-names>Mugip Rahaman</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Palaniyandi </surname><given-names>Thirunavukkarasu</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Wyson </surname><given-names>John</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Sivaji</surname><given-names>Asha</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Thamada</surname><given-names>Swarnakala</given-names></name></contrib></contrib-group>
      <pub-date pub-type="ppub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <pub-date pub-type="epub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <volume>16</volume>
      <issue>1</issue>
      <fpage>40</fpage>
      <lpage>48</lpage>
      <history>
        <date date-type="received">
          <day>19</day>
          <month>5</month>
          <year>2023</year>
        </date>
        <date date-type="accepted">
          <day>19</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </history>
      <abstract>
      <p>
      &lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Background:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Asparagine is an amino acid that can be converted into aspartic acid and ammonia by the enzyme L-asparaginase. Some forms of cancer, such Acute Lymphoblastic Leukaemia (ALL) and Non-Hodgkin Lymphoma (NHL), respond well to this enzyme when employed as a chemotherapeutic drug. The purpose of this research was to find bacteria that can manufacture the enzymes L-asparaginasein marine slattern sediment which can be employed in commercial and industrial scale production. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Methods:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; All of the strains were identified as &lt;em&gt;Bacillus &lt;/em&gt;&lt;/span&gt;&lt;em&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;niacini&lt;/span&gt;&lt;/em&gt;&lt;em&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; spp&lt;/span&gt;&lt;/em&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;. by biochemical and molecular testing. The strain belongs to the &lt;em&gt;Bacillus&lt;/em&gt; genus, according to nutritional, biochemical, PCR and 16srRNA sequencing data. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Results:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; According to the findings of this research, &lt;em&gt;Bacillus niacin spp.&lt;/em&gt; have the potential to create a substance that is helpful in a variety of medical applications. The results of this study hint to the possibility that bacteria have the ability to produce antimicrobial compounds, which have the potential to be successful in a wide variety of environments.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Conclusion:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Numerous opportunities may arise for researchers interested in utilizing the medical potential of enzyme-producing bacteria if they are successfully isolated and screened from aquatic and terrestrial habitats. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

      </p>
      </abstract>
    </article-meta>
  </front>
    
</article>
